Literature DB >> 9734394

Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions.

M P Piccinni1, L Beloni, C Livi, E Maggi, G Scarselli, S Romagnani.   

Abstract

Leukemia inhibitory factor is essential for embryo implantation, and a shift from type 1 T-helper to type 2 T-helper response at the fetal-maternal interface may contribute to successful pregnancy. We show that LIF production is associated with type 2 T-helper cells, is upregulated by IL-4 and progesterone and is downregulated by IL-12, IFN-gamma and IFN-alpha. We also show a decreased production of LIF, IL-4 and IL-10 by decidual T cells of women with unexplained recurrent abortions in comparison with that of women with normal gestation. The defective production of LIF and/or type 2 T-helper cytokines may contribute to the development of unexplained recurrent abortions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9734394     DOI: 10.1038/2006

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  103 in total

1.  Decidual T lymphocyte activation in hydatidiform mole.

Authors:  S Wongweragiat; R F Searle; J N Bulmer
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system.

Authors:  D Gestri; L Baldacci; R Taiuti; E Galli; E Maggi; M P Piccinni; M Vergelli; L Massacesi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 3.  Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?

Authors:  David A Clark
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

4.  The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines.

Authors:  N L Brown; S A Alvi; M G Elder; P R Bennett; M H Sullivan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

5.  A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy.

Authors:  H Tsuda; T Michimata; M Sakai; K Nagata; M Nakamura; S Saito
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 6.  The Immune System and the Role of Inflammation in Perinatal Depression.

Authors:  Philippe Leff-Gelman; Ismael Mancilla-Herrera; Mónica Flores-Ramos; Carlos Cruz-Fuentes; Juan Pablo Reyes-Grajeda; María Del Pilar García-Cuétara; Marielle Danitza Bugnot-Pérez; David Ellioth Pulido-Ascencio
Journal:  Neurosci Bull       Date:  2016-07-18       Impact factor: 5.203

7.  Variations in cytokine mRNA expression during normal human pregnancy.

Authors:  N Kruse; M Greif; N F Moriabadi; L Marx; K V Toyka; P Rieckmann
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

8.  Insufficient Angiogenesis: Cause of Abnormally Thin Endometrium in Subfertile Patients?

Authors:  Joachim Alfer; Lars Happel; Ralf Dittrich; Matthias W Beckmann; Arndt Hartmann; Andreas Gaumann; Volker U Buck; Irmgard Classen-Linke
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-07-17       Impact factor: 2.915

9.  Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model.

Authors:  Ana Claudia Zenclussen; Katrin Gerlof; Maria Laura Zenclussen; André Sollwedel; Annarosa Zambon Bertoja; Thomas Ritter; Katja Kotsch; Joachim Leber; Hans-Dieter Volk
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Decrease in invasion of HTR-8/SVneo trophoblastic cells by interferon gamma involves cross-communication of STAT1 and BATF2 that regulates the expression of JUN.

Authors:  Sonam Verma; Rahul Pal; Satish Kumar Gupta
Journal:  Cell Adh Migr       Date:  2018-02-20       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.